[Latest] Global Ultrasonic Dissection Devices Market Size/Share Worth USD 25 Billion by 2030 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
24 juil. 2023 13h30 HE
|
Custom Market Insights
Austin, TX, USA, July 24, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Ultrasonic Dissection Devices Market Size, Trends and Insights By Product...
Global Laparoscopic Devices Market Size To Grow USD 16.3 Billion By 2032 | CAGR of 8.5%
29 mai 2023 12h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , May 29, 2023 (GLOBE NEWSWIRE) -- The Global Laparoscopic Devices Market Size is to grow from USD 7.2 billion in 2022 to USD 16.3 billion by 2032, at a Compound Annual...
Suture Ease Showcases Two New Product Offerings at SAGES 2022
15 mars 2022 12h00 HE
|
Suture Ease
SAN JOSE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Suture Ease, a leading developer of medical devices that close fascial defects after laparoscopic surgery, will exhibit at the annual Society of...
Reprocessed Medical Devices Market ($4.5Bn by 2028) Growth Forecast at 14.5% CAGR During 2022 to 2028 COVID Impact and Global Analysis by Vantage Market Research
01 mars 2022 02h40 HE
|
Vantage Market Research
WASHINGTON, March 01, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Reprocessed Medical Devices Market finds that increasing the adoption of Reprocessed Medical...
Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5(TM) Topical Gel
25 juil. 2017 07h55 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jul 25, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics Presents Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
06 juin 2017 12h25 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Jun 6, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today...
Arch Therapeutics to Provide Corporate Update at the LD Micro Invitational on Tuesday, June 6, 2017
22 mai 2017 07h57 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - May 22, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be...
Arch Therapeutics to Provide Corporate Update at the 29th Annual Roth Conference on Monday, March 13, 2017
06 mars 2017 07h57 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Mar 6, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and...
Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference
27 févr. 2017 08h18 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Feb 27, 2017) - Terrence Norchi, MD, CEO of Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic...
Arch Therapeutics, Inc. $6.1 Million Registered Direct Offering
21 févr. 2017 09h08 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, MA--(Marketwired - Feb 21, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a developer of innovative materials as hemostatic and wound care devices, today...